Aevis Victoria (AEVS.SW) Stock Price

Aevis Victoria Price

SIX·CLOSED
12.90CHF+0.10 (+0.78 %)
Market closed

Over the last 19 years Aevis Victoria grew revenue by 28.6% annually, reaching 1.13 B CHF. Earnings per share have grown at 40.0% per year over the last 14 years. For Aevis Victoria, the net margin of -1.8% is down versus -0.5% a few years ago. At today's price the dividend yield works out to roughly 5.81%. The dividend has grown at 9.6% per year over the past 10 years. The consensus 12-month price target for Aevis Victoria is 17.34 CHF, about 34.4% above where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus. The stock trades about 6% above its 52-week low.

Aevis Victoria stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Aevis Victoria over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Aevis Victoria stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Aevis Victoria's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Aevis Victoria Stock Price History
DateAevis Victoria Price
8/10/202612.90 CHF
8/7/202612.80 CHF
8/6/202613.00 CHF
8/5/202612.80 CHF
8/4/202612.90 CHF
8/3/202612.70 CHF
7/31/202612.90 CHF
7/30/202613.30 CHF
7/29/202613.30 CHF
7/28/202613.30 CHF
7/27/202613.30 CHF
7/24/202612.95 CHF
7/23/202613.00 CHF
7/22/202613.00 CHF
7/21/202612.65 CHF
7/20/202612.80 CHF
7/17/202613.05 CHF
7/16/202612.90 CHF
7/15/202612.40 CHF
7/14/202613.10 CHF
7/13/202612.40 CHF
7/10/202612.25 CHF
7/9/202612.25 CHF
7/8/202612.20 CHF
7/7/202612.20 CHF
7/6/202612.20 CHF
7/3/202612.20 CHF
7/2/202612.25 CHF
7/1/202612.30 CHF
6/30/202612.35 CHF
6/29/202612.40 CHF
6/26/202612.45 CHF
6/25/202612.60 CHF
6/24/202612.70 CHF
6/23/202612.70 CHF
6/22/202613.20 CHF
6/19/202612.80 CHF
6/18/202612.60 CHF
6/17/202612.70 CHF
6/16/202612.70 CHF
6/15/202612.60 CHF
6/12/202612.60 CHF
6/11/202612.75 CHF
6/10/202612.95 CHF
6/9/202612.60 CHF
6/8/202612.95 CHF
6/5/202612.95 CHF
6/4/202612.80 CHF
6/3/202612.85 CHF
6/2/202612.90 CHF
6/1/202612.70 CHF
5/29/202613.00 CHF
5/28/202613.00 CHF
5/27/202612.90 CHF
5/26/202613.00 CHF
5/22/202613.20 CHF
5/21/202613.45 CHF
5/20/202613.60 CHF
5/19/202613.30 CHF
5/18/202613.15 CHF
5/15/202613.50 CHF
5/13/202613.40 CHF
5/12/202613.15 CHF
5/11/202613.55 CHF
5/8/202613.55 CHF
5/7/202613.60 CHF
5/6/202613.75 CHF
5/5/202613.50 CHF
5/4/202613.50 CHF
4/30/202613.65 CHF
4/29/202613.70 CHF
4/28/202613.70 CHF
4/27/202613.70 CHF
4/24/202613.60 CHF
4/23/202613.60 CHF
4/22/202613.50 CHF
4/21/202613.75 CHF
4/20/202613.75 CHF
4/17/202613.70 CHF
4/16/202613.70 CHF
4/15/202613.75 CHF
4/14/202613.95 CHF
4/13/202613.70 CHF
4/10/202613.15 CHF
4/9/202613.30 CHF
4/8/202613.30 CHF
4/7/202612.90 CHF
4/2/202612.85 CHF
3/27/202613.75 CHF
3/26/202613.55 CHF
3/25/202613.50 CHF
3/24/202613.60 CHF
3/23/202613.40 CHF
3/20/202613.50 CHF
3/19/202613.60 CHF
3/17/202613.60 CHF
3/16/202613.60 CHF
3/13/202613.73 CHF
3/12/202613.75 CHF
3/11/202613.90 CHF
3/10/202613.75 CHF
3/9/202614.00 CHF
3/6/202613.50 CHF
3/5/202613.35 CHF
3/4/202613.40 CHF
2/26/202613.65 CHF
2/25/202613.65 CHF
2/24/202613.50 CHF
2/23/202613.50 CHF
2/20/202613.55 CHF
2/19/202613.40 CHF
2/18/202613.25 CHF
2/17/202613.53 CHF
2/16/202613.53 CHF
2/13/202613.45 CHF
2/12/202613.65 CHF
2/11/202613.60 CHF
2/10/202613.63 CHF
2/9/202613.50 CHF
2/6/202613.40 CHF
2/5/202613.55 CHF
2/4/202613.30 CHF
2/3/202613.50 CHF
2/2/202613.70 CHF
1/30/202613.70 CHF
1/29/202613.80 CHF
1/28/202613.85 CHF
1/27/202613.65 CHF
1/26/202613.70 CHF
1/23/202613.80 CHF
1/22/202613.90 CHF
1/21/202613.40 CHF
1/20/202613.40 CHF
1/19/202613.40 CHF
1/16/202613.50 CHF
1/15/202613.50 CHF
1/14/202613.50 CHF
1/13/202613.45 CHF
1/12/202613.15 CHF
1/9/202613.45 CHF
1/8/202613.25 CHF
1/7/202613.25 CHF
1/6/202613.10 CHF
1/5/202613.35 CHF
12/30/202513.43 CHF
12/29/202513.50 CHF
12/23/202513.35 CHF
12/22/202513.50 CHF
12/19/202513.10 CHF
12/18/202513.00 CHF
12/17/202513.10 CHF
12/16/202513.00 CHF
12/15/202513.10 CHF
12/12/202513.10 CHF
12/11/202513.19 CHF
12/10/202513.00 CHF
12/9/202513.00 CHF
12/8/202512.98 CHF
12/5/202513.20 CHF
12/4/202512.87 CHF
12/3/202512.50 CHF
12/2/202512.40 CHF
12/1/202512.94 CHF
11/28/202513.00 CHF
11/27/202513.00 CHF
11/26/202512.90 CHF
11/25/202513.10 CHF
11/24/202513.45 CHF
11/21/202512.95 CHF
11/20/202513.10 CHF
11/19/202513.05 CHF
11/18/202513.05 CHF
11/17/202513.03 CHF
11/14/202512.80 CHF
11/13/202512.80 CHF
11/12/202512.80 CHF
11/11/202512.85 CHF
11/10/202512.70 CHF
11/7/202513.00 CHF
11/6/202513.00 CHF
11/5/202513.11 CHF
11/4/202513.45 CHF
11/3/202513.75 CHF
10/31/202513.40 CHF
10/30/202513.30 CHF
10/29/202513.25 CHF
10/28/202513.40 CHF
10/27/202513.25 CHF
10/24/202513.00 CHF
10/23/202513.10 CHF
10/22/202512.80 CHF
10/21/202513.00 CHF
10/20/202512.95 CHF
10/17/202513.25 CHF
10/16/202513.05 CHF
10/15/202513.05 CHF
10/14/202512.95 CHF
10/13/202513.15 CHF
10/10/202513.23 CHF
10/9/202513.20 CHF
10/8/202513.00 CHF
10/7/202513.15 CHF
10/6/202513.05 CHF
10/3/202513.35 CHF
10/2/202513.55 CHF
10/1/202513.40 CHF
9/29/202513.65 CHF
9/26/202513.65 CHF
9/25/202513.80 CHF
9/24/202513.95 CHF
9/23/202513.95 CHF
9/22/202513.95 CHF
9/19/202513.10 CHF
9/18/202513.60 CHF
9/17/202513.00 CHF
9/16/202513.50 CHF
9/15/202513.45 CHF
9/12/202513.45 CHF
9/11/202513.50 CHF
9/10/202513.58 CHF
9/9/202513.50 CHF
9/8/202513.68 CHF
9/5/202513.40 CHF
9/4/202513.50 CHF
9/3/202513.53 CHF
9/2/202513.45 CHF
9/1/202513.40 CHF
8/29/202513.20 CHF
8/28/202513.13 CHF
8/27/202513.00 CHF
8/26/202513.45 CHF
8/25/202513.20 CHF
8/22/202513.30 CHF
8/21/202513.30 CHF
8/20/202513.40 CHF
8/19/202513.15 CHF
8/18/202513.15 CHF
8/15/202513.15 CHF
8/14/202513.20 CHF
8/13/202513.15 CHF
Access this data via the Eulerpool API
Get Free API Key

Aevis Victoria Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
823.26 M CHF
22.53 M CHF
-4.27 M CHF
Jan 1, 2022
1.03 B CHF
61.71 M CHF
58.81 M CHF
Jan 1, 2023
914.36 M CHF
-12.88 M CHF
-39.30 M CHF
Jan 1, 2024
1.01 B CHF
32.26 M CHF
-2.87 M CHF
Jan 1, 2025
1.13 B CHF
-51.09 M CHF
-20.11 M CHF
Jan 1, 2026 (e)
1.07 B CHF
11.53 M CHF
10.11 M CHF
Jan 1, 2027 (e)
1.09 B CHF
11.89 M CHF
24.80 M CHF
Jan 1, 2028 (e)
1.17 B CHF
12.25 M CHF
36.60 M CHF

Aevis Victoria Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 13, 2026, 1:43 AM
 
REVENUEB CHF
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM CHF
EBITM CHF
EBIT MARGIN%
NET INCOMEM CHF
NET INCOME GROWTH%
DIV.CHF
DIV. GROWTH%
SHARESM
20132014201520162017201820192020202120222023202420252026e2027e2028e
0.450.480.510.520.580.580.700.700.821.030.911.011.131.071.091.17
31.986.614.961.7712.57-0.8620.80-0.1418.2525.15-11.2610.5012.08-5.742.446.59
68.5026.2425.0025.9225.4325.3017.0716.0916.6517.9618.6078.1217.0517.0517.0517.05
311.00127.00127.00134.00148.00146.00119.00112.00137.00185.00170.00789.00193.00181.92186.35198.63
26.0027.0023.0030.0036.0016.00177.00-44.0022.0061.00-12.0032.00-51.0011.0011.0012.00
5.735.584.535.806.192.7725.39-6.322.675.92-1.313.17-4.511.031.011.03
8.006.003.002.00–-8.00163.00-31.00-4.0058.00-39.00-2.00-20.0010.0024.0036.00
166.67-25.00-50.00-33.33––-2,137.50-119.02-87.10-1,550.00-167.24-94.87900.00-150.00140.0050.00
0.300.550.550.550.550.551.86––1.000.75––0.901.081.30
–83.33––––238.18–––-25.00–––20.0020.37
62.8673.6482.1481.1279.9279.6780.3380.2283.4290.0084.3484.1184.4284.4284.4284.42
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Aevis Victoria generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Aevis Victoria retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Aevis Victoria's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Aevis Victoria has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Aevis Victoria's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Aevis Victoria stock margins

The Aevis Victoria margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Aevis Victoria. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Aevis Victoria.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
16.71 %
2.74 %
-0.52 %
Jan 1, 2022
17.99 %
5.99 %
5.71 %
Jan 1, 2023
18.60 %
-1.41 %
-4.30 %
Jan 1, 2024
78.17 %
3.19 %
-0.28 %
Jan 1, 2025
17.04 %
-4.51 %
-1.77 %
Jan 1, 2026 (e)
17.04 %
1.08 %
0.95 %
Jan 1, 2027 (e)
17.04 %
1.09 %
2.27 %
Jan 1, 2028 (e)
17.04 %
1.05 %
3.14 %

Aevis Victoria Stock Revenue, EBIT, Earnings per Share

The Aevis Victoria earnings per share therefore indicates how much revenue Aevis Victoria has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
9.87 CHF
0.27 CHF
-0.05 CHF
Jan 1, 2022
11.45 CHF
0.69 CHF
0.65 CHF
Jan 1, 2023
10.84 CHF
-0.15 CHF
-0.47 CHF
Jan 1, 2024
12.01 CHF
0.38 CHF
-0.03 CHF
Jan 1, 2025
13.42 CHF
-0.61 CHF
-0.24 CHF
Jan 1, 2026 (e)
12.68 CHF
0.14 CHF
0.12 CHF
Jan 1, 2027 (e)
12.99 CHF
0.14 CHF
0.29 CHF
Jan 1, 2028 (e)
13.85 CHF
0.15 CHF
0.44 CHF

Aevis Victoria business model & stock analysis

Aevis Victoria SA is a Swiss company headquartered in Geneva. It was founded in 2006 and has developed a wide range of services over the years through strategic decisions and acquisitions. The history of Aevis Victoria began with the acquisition of three private clinics by founder Antoine Hubert. In 2007, the company started working on its first project, the Genolier Swiss Medical Network, a network of private clinics in Switzerland and France. Aevis Victoria has since made several other acquisitions, including a majority stake in Victoria-Jungfrau Collection AG, a renowned hotel group in Switzerland. Aevis Victoria's business model is based on investing in companies operating in the fields of healthcare, wellness, and lifestyle. The company offers a wide range of services including private clinics, spa and wellness centers, hotel and property management, and innovative technology and software for the healthcare and tourism industries. Among Aevis Victoria's various divisions, the Genolier Swiss Medical Network is the centerpiece. The network's clinics offer a comprehensive range of services including general medicine, surgery, obstetrics and gynecology, cardiology, neurology, and oncology. The network specializes in treating international patients and is globally recognized for its high quality medical care and sophisticated infrastructure. Aevis Victoria is also active in the field of spa and wellness centers. The group owns and operates several luxury wellness resorts, including the Victoria Jungfrau Grand Hotel & Spa in Interlaken and the La Réserve Genève Hotel & Spa in Geneva. These properties are equipped to the highest standards and offer a wide range of wellness and spa services tailored to the needs of discerning customers. In the hotel and property management sector, Aevis Victoria is a major player in the Swiss market and operates several prestigious hotels. In addition to Victoria-Jungfrau Collection AG, the group also owns the Carlton Hotel St. Moritz and the Hotel Royal Savoy Lausanne. When developing and implementing new real estate projects, Aevis Victoria places great importance on sustainability, quality, and innovation. Aevis Victoria also invests in innovative technologies and software for the healthcare and tourism industries. The company has previously financed several start-ups involved in the development of medical devices and digital platforms for the healthcare sector. The focus is on improving medical care and the patient experience. In summary, Aevis Victoria is a significant Swiss company in the field of healthcare, wellness, and lifestyle. The company's wide range of services, closely linked to its vision of high quality and innovation, is exemplary. Aevis Victoria will continue to invest in new technologies and services to expand its offerings and strengthen its position in these growing markets.

Aevis Victoria SWOT Analysis

Strengths

Aevis Victoria SA possesses several strengths that contribute to its competitive position in the market. These strengths include:

  • Strong financial performance and stability, enabling strategic investments and growth opportunities.
  • Diverse portfolio of high-quality healthcare assets, including hospitals, clinics, and senior care facilities.
  • Well-established brand reputation for delivering excellent healthcare services.
  • Experienced and skilled workforce, ensuring quality patient care.
  • Embracing technological advancements to enhance operational efficiency and patient outcomes.

Weaknesses

Despite its strengths, Aevis Victoria SA also faces certain weaknesses that may hinder its growth and performance. These weaknesses include:

  • Reliance on external financing for expansion projects, making it vulnerable to economic fluctuations and interest rate changes.
  • Limited geographical presence, which restricts market reach and potential customer base.
  • Dependency on key personnel and healthcare professionals, creating succession risks and talent retention challenges.
  • Potential regulatory compliance issues due to operating in multiple countries with different healthcare regulations.

Opportunities

Aevis Victoria SA can leverage the following opportunities to further strengthen its position in the market:

  • Increasing demand for healthcare services due to aging populations and rising healthcare needs worldwide.
  • Growing trend of medical tourism, offering opportunities to attract patients from diverse geographical locations.
  • Potential for strategic partnerships and joint ventures with other healthcare providers to expand market presence.
  • Advancements in technology and telemedicine, enabling innovative healthcare delivery models.

Threats

Aevis Victoria SA must also be aware of the following threats that may pose challenges to its success:

  • Intense competition from both local and international healthcare providers, increasing pricing pressures.
  • Changing healthcare regulations and policies, potentially leading to increased compliance costs and operational challenges.
  • Economic downturns and financial instability, negatively impacting the demand for non-essential healthcare services.
  • Rapid technological advancements leading to potential disruption of traditional healthcare business models.

Aevis Victoria Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Aevis Victoria historical P/E ratio, EBIT multiple, and P/S ratio

Aevis Victoria annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Aevis Victoria shares outstanding

The number of shares of Aevis Victoria was 84.42 M in 2025. This indicates how many shares Aevis Victoria is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
83.42 M Stocks
Jan 1, 2022
90.00 M Stocks
Jan 1, 2023
84.34 M Stocks
Jan 1, 2024
84.11 M Stocks
Jan 1, 2025
84.42 M Stocks
Jan 1, 2026 (e)
84.42 M Stocks
Jan 1, 2027 (e)
84.42 M Stocks
Jan 1, 2028 (e)
84.42 M Stocks

Aevis Victoria stock splits

In Aevis Victoria's history, there have been no stock splits.

Aevis Victoria Dividend History

9 years of dividend payments

YearAnnual DividendYoY ChangePayments
20230.75CHF↓ 25.0%2×
20221.00CHF↓ 46.2%2×
20191.86CHF↑ 238.2%2×
20180.55CHF 0.0%1×
20170.55CHF 0.0%1×
20160.55CHF 0.0%1×
20150.55CHF 0.0%1×
20140.55CHF↑ 83.3%1×
20130.30CHF—1×

Aevis Victoria dividend payout ratio

In 2025, Aevis Victoria had a payout ratio of 148.62%. The payout ratio indicates the percentage of the company's profits that Aevis Victoria distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
132.39 %
Jan 1, 2022
153.03 %
Jan 1, 2023
-160.98 %
Jan 1, 2024
160.44 %
Jan 1, 2025
148.62 %
Jan 1, 2026 (e)
748.75 %
Jan 1, 2027 (e)
366.35 %
Jan 1, 2028 (e)
297.93 %

Current Aevis Victoria forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
85.71 % (6)
Hold
14.29 % (1)
Sell
0.00 % (0)
12M Price Target
17.34
Last Price
12.90
Currency
CHF
12M Return Potential
34.42 %
LTM Return
0 %

EESG©

Eulerpool ESG Scorecard© for the Aevis Victoria stock

46/100
39
Environment
78
Social
21
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees40.8
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Aevis Victoria shareholder structure

% Name
0.40422%
UBS Fund Management (Switzerland) AG
UBS Fund Management (Switzerland) AG
0.30038%
UBS Asset Management (Switzerland)
UBS Asset Management (Switzerland)
0.29358%
3V Asset Management AG
3V Asset Management AG
0.21381%
Zürcher Kantonalbank (Asset Management)
Zürcher Kantonalbank (Asset Management)
0.08790%
BlackRock Advisors (UK) Limited
BlackRock Advisors (UK) Limited
0.02255%
DWS International GmbH
DWS International GmbH

Aevis Victoria Beneficial Ownership Filings (SEC 13D/G)

Free Float
11.8%
Float Shares
-
Shares Outstanding
-

Aevis Victoria Executives and Management Board

10 members · avg. age 64 · 10 % women

Management

FZ

Mr. Fabrice Zumbrunnen (56)

Chief Executive Officer

–
MK

Mr. Michel Keusch (55)

Chief Financial Officer

–
SV

Ms. Severine Vanderschueren (55)

Chief Administrative Officer

–
PB

Mr. Philippe Blangey

Investor Relations Officer

–

Board of Directors

AH

Mr. Antoine Hubert (59)

Member of the Management Board, Delegate of the Board of Directors

1.71 M CHF
RL

Mr. Raymond Loretan (70)

Non-Executive Independent Vice Chairman of the Board · since 2006

771,300.00 CHF
AK

Mr. Antoine Kohler (69)

Non-Executive Independent Member of the Board

112,600.00 CHF
CW

Dr. Christian Wenger (61)

Non-Executive Independent Chairman of the Board

104,400.00 CHF
CG

Dr. Cedric George (73)

Non-Executive Independent Member of the Board

56,200.00 CHF
MR

Mr. Michel Reybier (80)

Non-Executive Member of the Board

52,600.00 CHF

Frequently asked questions about Aevis Victoria

Aevis Victoria SA is a healthcare company with a diversified business model. It operates in the areas of acute care hospitals, post-acute care facilities, medical clinics, and health networks. Aevis Victoria SA aims to provide high-quality medical services, combining modern infrastructure and cutting-edge technology. The company's diverse portfolio includes private hospitals, rehabilitation clinics, residential care centers, and other healthcare facilities. Aevis Victoria SA is committed to offering comprehensive and patient-centric care, implementing innovative medical solutions, and continuously enhancing the overall healthcare experience. With its strong presence and expertise in the healthcare industry, Aevis Victoria SA strives to deliver exceptional services and contribute to improving the overall well-being of individuals and communities.

Aevis Victoria SA is primarily active in the healthcare and hospitality industries.

The main competitors of Aevis Victoria SA in the market include Swiss Medical Network, Mediclinic International, and Infracore SA.

Aevis Victoria SA is a leading healthcare and hospitality company headquartered in Switzerland. Established in 1995, Aevis Victoria SA has a rich history and background in providing exceptional services in the healthcare industry. Over the years, the company has expanded its operations to include a wide range of healthcare facilities, including private hospitals, clinics, and medical services. Aevis Victoria SA has also ventured into the hospitality sector, managing luxury hotels and resorts. With a strong commitment to quality and innovation, Aevis Victoria SA has gained a reputation for delivering excellent healthcare and hospitality experiences.

Aevis Victoria SA has achieved several significant milestones. The company expanded its healthcare division by acquiring Swiss Medical Network, one of the largest private hospital networks in Switzerland. Aevis Victoria SA also made strategic investments in the hospitality industry, acquiring luxury hotel and tourism assets. In addition, the company launched a digital health platform called Medgate, providing telemedicine services. Aevis Victoria SA has further extended its presence by acquiring minority stakes in various healthcare companies. Overall, Aevis Victoria SA has demonstrated a track record of successful acquisitions and investments, expanding its portfolio and solidifying its position in both the healthcare and hospitality sectors.

Aevis Victoria SA is primarily present in Switzerland.

Aevis Victoria SA represents values of excellence, innovation, and integrity in its corporate philosophy. As a leading company in the healthcare and hospitality sectors, Aevis Victoria SA focuses on delivering superior services and enhancing the well-being of its clients. With a commitment to sustainability and social responsibility, the company aims to contribute positively to the communities it operates in. Aevis Victoria SA prioritizes customer satisfaction, providing personalized experiences and maintaining highest standards in quality. By championing continuous improvement and fostering a culture of collaboration, Aevis Victoria SA assures stakeholders of their dedication to long-term success and creating value in their respective industries.

Analysts currently set an average price target of 17.34 CHF for the Aevis Victoria stock (median: 17.34 CHF), implying +34.4 % versus the latest price. The consensus is based on 7 analyst ratings.

Aevis Victoria Analyst Price Targets 2026

7 analysts currently rate the Aevis Victoria stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Aevis Victoria to generate revenue of 1.07 B CHF and earnings per share of 0.12 CHF.

Aevis Victoria Analyst Price Targets 2026

Converted at the current exchange rate, the Aevis Victoria share trades at 13.78 EUR (12.90 CHF).

The Aevis Victoria share (AEVS.SW) is listed on 2 stock exchanges, including: Frankfurt (G5LN.F), SIX (Zürich) (AEVS.SW).

Aevis Victoria SA is an internationally operating company that is active in the fields of Life Sciences, Hospitality, and Lifestyle. The company is headquartered in Lausanne, Switzerland and is listed on the Swiss SIX Swiss Exchange. The Life Sciences division of Aevis Victoria SA focuses on the development, manufacturing, and marketing of medical devices and medications. This includes artificial joints, implantable pacemakers, and insulin pumps. The company partners with leading healthcare organizations worldwide and works closely with renowned research institutes to develop innovative solutions for medical problems. The Hospitality division of Aevis Victoria SA encompasses a variety of luxury hotels and resorts throughout Europe. Some of the well-known brands include The Alpina Gstaad in Switzerland, Ushuaïa Ibiza Beach Hotel in Spain, and Miraggio Thermal Spa Resort in Greece. The Hospitality division aims to provide its guests with an unforgettable experience by setting the luxury standard in the industry and offering excellent customer service. The Lifestyle division of Aevis Victoria SA focuses on the marketing of exclusive lifestyle products such as fashion, jewelry, and watches. This includes brands like Caran d'Ache, de Grisogono, and Peter Zwack. The Lifestyle division strives to delight its customers through a combination of elegance and style and deliver products of the highest quality. Aevis Victoria SA aims to provide customers with a seamless shopping experience by selling its products online and in physical stores worldwide. The company's strategy is based on the development of innovative products and services that cater to the needs of its customers. Additionally, the company aims to expand its strong presence in Europe and Asia to strengthen its position in the global market. Overall, the business model of Aevis Victoria SA combines innovative research and development, excellent customer service, and a wide range of products. The company aims to be a leading player in the fields of Life Sciences, Hospitality, and Lifestyle and provide its customers with an unforgettable experience through excellent products and services. With its strong brand portfolio and global presence, the company is well-positioned to continue growing and strengthen its position in the global market.

The expected revenue of Aevis Victoria is 1.07 B CHF. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Aevis Victoria is 10.11 M CHF. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Aevis Victoria is currently 107.68. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Aevis Victoria stock.

The price-to-sales ratio (P/S) of Aevis Victoria is currently 1.02. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Aevis Victoria stock.

The Eulerpool Quality Score for Aevis Victoria is 2/10.

The ISIN of Aevis Victoria is CH0478634105. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Aevis Victoria is A2PLW7. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Aevis Victoria is AEVS.SW. The ticker symbol is used to trade Aevis Victoria shares on the stock exchange.

Over the past 12 months, Aevis Victoria paid a dividend of 0.75 CHF . This corresponds to a dividend yield of about 5.81 %. For the coming 12 months, Aevis Victoria is expected to pay a dividend of 1.08 CHF.

The current dividend yield of Aevis Victoria is 5.81 %.

Aevis Victoria pays a dividend, distributed in the months of , , , .

Aevis Victoria paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 1.08 CHF are expected. This corresponds to a dividend yield of 8.37 %.

Aevis Victoria is assigned to the 'Health' sector.

To receive the latest dividend of Aevis Victoria from amounting to 0.3 CHF, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

The dividends of Aevis Victoria are distributed in CHF.

All fundamentals and in-depth analysis of Aevis Victoria

Our stock analysis for Aevis Victoria stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aevis Victoria. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Aevis Victoria Stock
Aevis Victoria Revenue→
Aevis Victoria Stock
Aevis Victoria Net Income→
Aevis Victoria Stock
Aevis Victoria P/E→
Aevis Victoria Stock
Aevis Victoria P/S→
Aevis Victoria Stock
Aevis Victoria EBIT→
Aevis Victoria Stock
Aevis Victoria Dividend→
Aevis Victoria Stock
Aevis Victoria Directors Dealings→
Aevis Victoria Stock
Aevis Victoria Stocks→
Aevis Victoria Stock
Aevis Victoria Market capitalization→
Aevis Victoria Stock
Aevis Victoria Debt→
Aevis Victoria Stock
Aevis Victoria Liabilities→
Aevis Victoria Stock
Aevis Victoria Equity→
Aevis Victoria Stock
Aevis Victoria AAQS→
Aevis Victoria Stock
Aevis Victoria Employees→
Aevis Victoria Stock
Aevis Victoria ROE→
Aevis Victoria Stock
Aevis Victoria ROA→
Aevis Victoria Stock
Aevis Victoria ROCE→
Aevis Victoria Stock
Aevis Victoria News→
Aevis Victoria Stock
Aevis Victoria Analyst Price Targets→

Health Stocks

AFT PharmaceuticalsAethlon MedicalAgape ATPAether IndustriesAgenusAesthetic Connect PCLAGFA GevaertAeolus PharmaceuticalsAgilent TechnologiesAelis Farmaagilon health incAdynxxAll Stocks A–Z →